Athersys - Stock Price History | ATHX

Historical daily share price chart and data for Athersys since 2019 adjusted for splits. The latest closing stock price for Athersys as of December 05, 2019 is 1.30.
  • The all-time high Athersys stock closing price was 8.50 on July 16, 2007.
  • The Athersys 52-week high stock price is 2.15, which is 65.4% above the current share price.
  • The Athersys 52-week low stock price is 1.20, which is 7.7% below the current share price.
  • The average Athersys stock price for the last 52 weeks is 1.50.
Athersys Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 1.9521 1.8100 2.7900 1.3400 1.4400 -20.44%
2017 1.6273 1.5400 2.5500 1.0900 1.8100 18.30%
2016 1.9333 1.0100 2.6450 1.0000 1.5300 48.54%
2015 1.5402 1.6600 3.2700 0.9850 1.0300 -34.81%
2014 2.1274 2.9500 4.1800 1.1500 1.5800 -36.80%
2013 1.7352 1.1500 2.5000 1.1300 2.5000 135.85%
2012 1.4765 1.8600 2.1400 0.9510 1.0600 -38.73%
2011 2.3018 2.6200 3.0100 1.1800 1.7300 -29.96%
2010 2.9644 4.0400 4.0400 2.3766 2.4700 -40.19%
2009 1.0316 0.4700 5.5500 0.4700 4.1300 817.57%
2008 2.5442 4.9100 5.0000 0.3201 0.4501 -90.83%
2007 6.5556 5.2500 8.5000 3.9000 4.9100 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.205B $0.024B
Athersys, Inc., a late stage biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused primarily on treating critical care indications neurological conditions, cardiovascular diseases, inflammatory and immune disorders, pulmonary and other conditions. The company's lead platform product is MultiStem cell therapy, an `off the shelf` allogeneic stem cell product currently in Phase 3 clinical development for treating ischemic stroke. Based on promising Phase 2 results, this program has received Fast Track and RMAT (equivalent to Breakthrough Therapy for regenerative medicine treatments) designations from the FDA, as well as similar designations in Japan. The company also has an ongoing Phase II clinical study for treating patients with acute myocardial infarction; a planned Phase II for trauma (supported by the DOD).
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.968B 16.01
CSL (CSLLY) Australia $86.243B 0.00
Gilead Sciences (GILD) United States $84.448B 10.46
Vertex Pharmaceuticals (VRTX) United States $57.578B 58.77
Biogen (BIIB) United States $52.242B 8.97
Illumina (ILMN) United States $46.993B 51.56
Regeneron Pharmaceuticals (REGN) United States $40.620B 17.79
Alexion Pharmaceuticals (ALXN) United States $25.548B 12.62
Incyte (INCY) United States $20.463B 47.50
Seattle Genetics (SGEN) United States $20.283B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.057B 0.00
Genmab (GNMSF) Denmark $14.991B 66.21
BioMarin Pharmaceutical (BMRN) United States $14.602B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.600B 0.00
Galapagos (GLPG) Belgium $11.277B 29.06
Exact Sciences (EXAS) United States $10.777B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
QIAGEN (QGEN) Netherlands $9.449B 30.81
BeiGene (BGNE) Cayman Islands $9.241B 0.00
Bio-Techne Corp (TECH) United States $8.323B 55.71
Sarepta Therapeutics (SRPT) United States $8.303B 0.00
Amarin (AMRN) Ireland $8.137B 0.00
Moderna (MRNA) United States $7.088B 0.00
Guardant Health (GH) United States $7.039B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.820B 0.00
Medicines (MDCO) United States $6.702B 0.00
Reata Pharmaceuticals (RETA) United States $6.193B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.110B 15.53
ARGENX SE-ADR (ARGX) Netherlands $5.754B 0.00
Exelixis (EXEL) United States $5.369B 15.10
Ascendis Pharma (ASND) Denmark $4.898B 0.00
BioNTech SE (BNTX) Germany $4.835B 0.00
Repligen (RGEN) United States $4.613B 83.59
China Biologic Products (CBPO) China $4.606B 25.94
Bluebird Bio (BLUE) United States $4.488B 0.00
Spark Therapeutics (ONCE) United States $4.237B 0.00
Mirati Therapeutics (MRTX) United States $4.164B 0.00
MorphoSys AG (MOR) Germany $4.062B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.980B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.851B 0.00
Blueprint Medicines (BPMC) United States $3.695B 0.00
Immunomedics (IMMU) United States $3.482B 0.00
Adaptive Biotechnologies (ADPT) United States $3.378B 0.00
Alkermes (ALKS) Ireland $3.344B 0.00
Genmab (GMAB) Denmark $3.108B 6.40
MyoKardia (MYOK) United States $3.101B 0.00
Halozyme Therapeutics (HALO) United States $2.853B 0.00
UniQure (QURE) Netherlands $2.852B 0.00
Emergent Biosolutions (EBS) United States $2.794B 27.75
Amicus Therapeutics (FOLD) United States $2.739B 0.00
NeoGenomics (NEO) United States $2.709B 144.17
Acceleron Pharma (XLRN) United States $2.594B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.463B 0.00
Zai Lab (ZLAB) China $2.374B 0.00
Arena Pharmaceuticals (ARNA) United States $2.354B 5.47
RA PHARMCTL INC (RARX) United States $2.209B 0.00
Insmed (INSM) United States $2.087B 0.00
Myriad Genetics (MYGN) United States $1.921B 28.39
Ligand Pharmaceuticals (LGND) United States $1.889B 36.35
Dicerna Pharmaceuticals (DRNA) United States $1.841B 0.00
Denali Therapeutics (DNLI) United States $1.743B 0.00
Zymeworks (ZYME) Canada $1.737B 0.00
Akcea Therapeutics (AKCA) United States $1.731B 0.00
REGENXBIO (RGNX) United States $1.652B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.641B 0.00
Editas Medicine (EDIT) United States $1.579B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.520B 0.00
Epizyme (EPZM) United States $1.440B 0.00
Sangamo Therapeutics (SGMO) United States $1.356B 0.00
Alector (ALEC) United States $1.352B 0.00
Innoviva (INVA) United States $1.324B 3.90
Arvinas (ARVN) United States $1.314B 0.00
Coherus BioSciences (CHRS) United States $1.283B 0.00
Athenex (ATNX) United States $1.248B 0.00
WAVE Life Sciences (WVE) Singapore $1.212B 0.00
Principia Biopharma (PRNB) United States $1.184B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.130B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Fate Therapeutics (FATE) United States $1.073B 0.00
Zealand Pharma (ZEAL) Denmark $1.041B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.958B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.915B 7.69
Codexis (CDXS) United States $0.897B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.864B 0.00
Intellia Therapeutics (NTLA) United States $0.864B 0.00
Precision BioSciences (DTIL) United States $0.845B 0.00
Pharming Group (PHGUF) Netherlands $0.840B 0.00
Vericel (VCEL) United States $0.839B 312.75
Anika Therapeutics (ANIK) United States $0.814B 26.42
MiMedx (MDXG) United States $0.813B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.792B 0.00
Twist Bioscience (TWST) United States $0.772B 0.00
Heska (HSKA) United States $0.752B 192.20
Revance Therapeutics (RVNC) United States $0.749B 0.00
Adverum Biotechnologies (ADVM) United States $0.732B 0.00
ANI Pharmaceuticals (ANIP) United States $0.726B 12.39
DBV Technologies S.A (DBVT) France $0.726B 0.00
Cara Therapeutics (CARA) United States $0.682B 0.00
Clovis Oncology (CLVS) United States $0.664B 0.00
UROGEN PHARMA (URGN) United States $0.652B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.639B 0.00
Mesoblast (MESO) Australia $0.625B 0.00
Cellectis S.A (CLLS) France $0.619B 0.00
BioDelivery Sciences (BDSI) United States $0.600B 0.00
Sorrento Therapeutics (SRNE) United States $0.599B 0.00
GENFIT S.A (GNFT) France $0.594B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
Cytokineticsorporated (CYTK) United States $0.579B 0.00
Retrophin (RTRX) United States $0.570B 0.00
Intra-Cellular Therapies (ITCI) United States $0.552B 0.00
PHARMA MAR SA (PHMMF) Spain $0.549B 0.00
Kadmon Holdings (KDMN) United States $0.543B 0.00
Agenus (AGEN) United States $0.541B 0.00
AC Immune SA (ACIU) Switzerland $0.523B 12.09
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Prothena (PRTA) Ireland $0.492B 0.00
Stemline Therapeutics (STML) United States $0.487B 0.00
Dynavax Technologies (DVAX) United States $0.478B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.401B 2.77
Merus (MRUS) Netherlands $0.397B 0.00
AnaptysBio (ANAB) United States $0.392B 0.00
Bellus Health (BLU) Canada $0.386B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.369B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.363B 0.00
Arcus Biosciences (RCUS) United States $0.363B 0.00
Puma Biotechnology (PBYI) United States $0.349B 0.00
Cellular Biomedicine (CBMG) United States $0.348B 0.00
Pfenex (PFNX) United States $0.344B 0.00
Starpharma Holdings (SPHRY) Australia $0.343B 0.00
OSMOTICA PHARM (OSMT) United States $0.338B 0.00
PDL BioPharma (PDLI) United States $0.335B 8.37
Avid Bioservices (CDMO) United States $0.324B 0.00
Gritstone Oncology (GRTS) United States $0.301B 0.00
Kindred Biosciences (KIN) United States $0.300B 0.00
Geron (GERN) United States $0.298B 0.00
CytomX Therapeutics (CTMX) United States $0.296B 0.00
Kamada (KMDA) Israel $0.293B 8.56
Cue Biopharma (CUE) United States $0.290B 0.00
Compugen (CGEN) Israel $0.281B 0.00
Albireo Pharma (ALBO) United States $0.271B 0.00
Cel-Sci (CVM) United States $0.267B 0.00
Seres Therapeutics (MCRB) United States $0.260B 0.00
MannKind (MNKD) United States $0.256B 0.00
Sutro Biopharma (STRO) United States $0.254B 0.00
ADMA Biologics Inc (ADMA) United States $0.251B 0.00
Scholar Rock Holding (SRRK) United States $0.248B 0.00
Inovio Pharmaceuticals (INO) United States $0.247B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.234B 0.00
Exicure (XCUR) United States $0.230B 0.00
Biofrontera AG (BFRA) Germany $0.226B 0.00
Theratechnologies (THTX) Canada $0.223B 0.00
Protagonist Therapeutics (PTGX) United States $0.221B 0.00
Senesco Technologies (ELOX) United States $0.219B 0.00
Spero Therapeutics (SPRO) United States $0.217B 0.00
ChromaDex (CDXC) United States $0.217B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.216B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
XOMA (XOMA) United States $0.210B 0.00
Syros Pharmaceuticals (SYRS) United States $0.201B 0.00
Mersana Therapeutics (MRSN) United States $0.200B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.197B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.187B 0.00
Palatin Technologies (PTN) United States $0.186B 5.09
Affimed (AFMD) Germany $0.178B 0.00
ARAVIVE, INC (ARAV) United States $0.176B 0.00
IVERIC Bio (ISEE) United States $0.170B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.167B 0.00
Dyadic (DYAI) United States $0.163B 0.00
Cerecor (CERC) United States $0.163B 0.00
CorMedix Inc (CRMD) United States $0.155B 0.00
Alcobra (ARCT) United States $0.153B 0.00
Abeona Therapeutics (ABEO) United States $0.153B 0.00
NantKwest (NK) United States $0.151B 0.00
VBI Vaccines (VBIV) United States $0.147B 0.00
Fortress Biotech (FBIO) United States $0.146B 0.00
Five Prime Therapeutics (FPRX) United States $0.146B 0.00
TELA Bio (TELA) United States $0.145B 0.00
Proteostasis Therapeutics (PTI) United States $0.143B 0.00
Prometic Life Sciences (LMNL) Canada $0.140B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Aptinyx (APTX) United States $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Enzo Biochem (ENZ) United States $0.131B 0.00
Novavax (NVAX) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
Arbutus Biopharma (ABUS) Canada $0.128B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.128B 0.00
Arsanis (XFOR) United States $0.127B 0.00
Nicox SA (NICXF) France $0.126B 0.00
Celyad SA (CYAD) Belgium $0.126B 0.00
SESEN BIO, INC (SESN) United States $0.126B 0.00
BioTime (LCTX) United States $0.123B 6.31
AVEO Pharmaceuticals (AVEO) United States $0.121B 0.00
OvaScience (MLND) United States $0.105B 0.00
Emmaus Life Sciences (EMMA) United States $0.103B 0.00
Verastem (VSTM) United States $0.102B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.101B 0.00
Strongbridge Biopharma (SBBP) United States $0.098B 2.62
Aduro Biotech (ADRO) United States $0.096B 0.00
Menlo Therapeutics (MNLO) United States $0.095B 0.00
PHASEBIO PHARMA (PHAS) United States $0.094B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.088B 0.00
Acorda Therapeutics (ACOR) United States $0.088B 0.00
Antibe Therapeutics (ATBPF) Canada $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
Liquidia Technologies (LQDA) United States $0.079B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Synlogic (SYBX) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
Clearside Biomedical (CLSD) United States $0.068B 0.00
Organovo Holdings (ONVO) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.063B 0.00
Catalyst Biosciences (CBIO) United States $0.063B 0.00
Trevena (TRVN) United States $0.062B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.062B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Curis (CRIS) United States $0.059B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.059B 0.00
Applied Genetic Technologies (AGTC) United States $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.052B 0.00
AIT Therapeutics (XAIR) United States $0.050B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Checkpoint Therapeutics (CKPT) United States $0.048B 0.00
Orgenesis (ORGS) United States $0.046B 2.97
Protalix BioTherapeutics (PLX) Israel $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.043B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.043B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Celldex Therapeutics (CLDX) United States $0.040B 0.00
Oncobiologics (OTLK) United States $0.038B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
Alimera Sciences (ALIM) United States $0.036B 0.00
Evogene (EVGN) Israel $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Celsion (CLSN) United States $0.033B 0.00
BioCardia (BCDA) United States $0.031B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.61
Aptevo Therapeutics (APVO) United States $0.029B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Apricus Biosciences (SEEL) United States $0.025B 0.00
Entera Bio (ENTX) Israel $0.025B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.024B 0.00
Bionano Genomics (BNGO) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Unum Therapeutics (UMRX) United States $0.021B 0.00
Soligenix (SNGX) United States $0.021B 0.00
VistaGen Therapeutics (VTGN) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Advaxis (ADXS) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
IBio (IBIO) United States $0.009B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
Cleveland BioLabs (CBLI) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.004B 0.00